Cargando…

Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein

Dengue virus (DENV) infection imposes enormous health and economic burden worldwide with no approved treatment. Several small molecules, including lovastatin, celgosivir, balapiravir and chloroquine have been tested for potential anti-dengue activity in clinical trials; none of these have demonstrat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Budigi, Yadunanda, Ong, Eugenia Z., Robinson, Luke N., Ong, Li Ching, Rowley, Kirk J., Winnett, Alexander, Tan, Hwee Cheng, Hobbie, Sven, Shriver, Zachary, Babcock, Gregory J., Alonso, Sylvie, Ooi, Eng Eong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823465/ https://www.ncbi.nlm.nih.gov/pubmed/29425203 http://dx.doi.org/10.1371/journal.pntd.0006209

Ejemplares similares

Dengue virus compartmentalization during antibody-enhanced infection
por: Ong, Eugenia Z., et al.
Publicado: (2017)

Hypoxia enhances antibody‐dependent dengue virus infection
por: Gan, Esther Shuyi, et al.
Publicado: (2017)

Serum Metabolome and Lipidome Changes in Adult Patients with Primary Dengue Infection
por: Cui, Liang, et al.
Publicado: (2013)

Dengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral Serotypes
por: Poggianella, Monica, et al.
Publicado: (2015)

Proteasome Inhibition Suppresses Dengue Virus Egress in Antibody Dependent Infection
por: Choy, Milly M., et al.
Publicado: (2015)

Dengue Mosaic Vaccines Enhance Cellular Immunity and Expand the Breadth of Neutralizing Antibody Against All Four Serotypes of Dengue Viruses in Mice
por: Hou, Jue, et al.
Publicado: (2019)

Antibody-Dependent Dengue Virus Entry Modulates Cell Intrinsic Responses for Enhanced Infection
por: Chan, Candice Y. Y., et al.
Publicado: (2019)

Molecular basis for dengue virus broad cross-neutralization by humanized monoclonal antibody 513
por: Wong, Yee Hwa, et al.
Publicado: (2018)

The re-emergence of dengue in China
por: Ooi, Eng Eong
Publicado: (2015)

First Experimental In Vivo Model of Enhanced Dengue Disease Severity through Maternally Acquired Heterotypic Dengue Antibodies
por: Ng, Jowin Kai Wei, et al.
Publicado: (2014)

Serum Proteome and Cytokine Analysis in a Longitudinal Cohort of Adults with Primary Dengue Infection Reveals Predictive Markers of DHF
por: Kumar, Yadunanda, et al.
Publicado: (2012)

Serum metabolome changes in adult patients with severe dengue in the critical and recovery phases of dengue infection
por: Cui, Liang, et al.
Publicado: (2018)

Sequential immunization induces strong and broad immunity against all four dengue virus serotypes
por: Hou, Jue, et al.
Publicado: (2020)

Serum Metabolomics Reveals Serotonin as a Predictor of Severe Dengue in the Early Phase of Dengue Fever
por: Cui, Liang, et al.
Publicado: (2016)

Attenuated dengue viruses are genetically more diverse than their respective wild-type parents
por: Bifani, Amanda Makha, et al.
Publicado: (2021)

Evolution of Subgenomic RNA Shapes Dengue Virus Adaptation and Epidemiological Fitness
por: Finol, Esteban, et al.
Publicado: (2019)

A fast-growing dengue virus mutant reveals a dual role of STING in response to infection
por: Ng, Wy Ching, et al.
Publicado: (2022)

Augmentation of 5-lipoxygenase activity and expression during dengue serotype-2 infection
por: Loke, Wai Mun, et al.
Publicado: (2013)

A Human PrM Antibody That Recognizes a Novel Cryptic Epitope on Dengue E Glycoprotein
por: Chan, Annie Hoi Yi, et al.
Publicado: (2012)

Current Status of Dengue Therapeutics Research and Development
por: Low, Jenny G. H., et al.
Publicado: (2017)

Dengue Reporter Virus Particles for Measuring Neutralizing Antibodies against Each of the Four Dengue Serotypes
por: Mattia, Kimberly, et al.
Publicado: (2011)

Dengue virus antibody database: Systematically linking serotype-specificity with epitope mapping in dengue virus
por: Chaudhury, Sidhartha, et al.
Publicado: (2017)

Dengue Prevention and 35 Years of Vector Control in Singapore
por: Ooi, Eng-Eong, et al.
Publicado: (2006)

DengueSeq: A pan-serotype whole genome amplicon sequencing protocol for dengue virus
por: Vogels, Chantal B.F., et al.
Publicado: (2023)

Ophthalmic manifestations in seropositive dengue fever patients during epidemics caused by predominantly different dengue serotypes
por: Wagle, Ajeet M., et al.
Publicado: (2022)

Dengue Virus Neutralization in Cells Expressing Fc Gamma Receptors
por: Chawla, Tanu, et al.
Publicado: (2013)

Evaluation of the NS1 Rapid Test and the WHO Dengue Classification Schemes for Use as Bedside Diagnosis of Acute Dengue Fever in Adults
por: Chaterji, Shera, et al.
Publicado: (2011)

Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses
por: Wahala, Wahala M. P. B., et al.
Publicado: (2010)

Fc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseases
por: Chan, Kuan Rong, et al.
Publicado: (2015)

Potent Neutralization Ability of a Human Monoclonal Antibody Against Serotype 1 Dengue Virus
por: Lu, Jiansheng, et al.
Publicado: (2018)

Revisiting dengue virus-mosquito interactions: molecular insights into viral fitness
por: Siriphanitchakorn, Tanamas, et al.
Publicado: (2021)

Pediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue Virus
por: Brandler, Samantha, et al.
Publicado: (2007)

Induction of Neutralizing Antibodies against Four Serotypes of Dengue Viruses by MixBiEDIII, a Tetravalent Dengue Vaccine
por: Zhao, Hui, et al.
Publicado: (2014)

Serum Metabolomics Investigation of Humanized Mouse Model of Dengue Virus Infection
por: Cui, Liang, et al.
Publicado: (2017)

Preventing Dengue Epidemics during the COVID-19 Pandemic
por: Wilder-Smith, Annelies, et al.
Publicado: (2020)

Dengue virus activates cGAS through the release of mitochondrial DNA
por: Sun, Bo, et al.
Publicado: (2017)

Production of Infectious Dengue Virus in Aedes aegypti Is Dependent on the Ubiquitin Proteasome Pathway
por: Choy, Milly M., et al.
Publicado: (2015)

Dengue virus induces PCSK9 expression to alter antiviral responses and disease outcomes
por: Gan, Esther Shuyi, et al.
Publicado: (2020)

Characterization of early host responses in adults with dengue disease
por: Tolfvenstam, Thomas, et al.
Publicado: (2011)

Molecular determinants of plaque size as an indicator of dengue virus attenuation
por: Goh, Kenneth Choon Meng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bpnmo6c81mgm1u6rs9lg68it0s